國立虎尾科技大學 |

Probiotic research in therapeutics.. Volume 5,. Metabolic diseases and gut bacteria

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Probiotic research in therapeutics./ edited by Indu Pal Kaur ... [et al.].
remainder title:	Metabolic diseases and gut bacteria
other author:	Kaur, Indu Pal.
Published:	Singapore :Springer Nature Singapore : : 2022.,
Description:	xiv, 275 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
Subject:	Probiotics. -
Online resource:	https://doi.org/10.1007/978-981-16-8444-9
ISBN:	9789811684449

Probiotic research in therapeutics.. Volume 5,. Metabolic diseases and gut bacteria
Probiotic research in therapeutics.Volume 5,Metabolic diseases and gut bacteria[electronic resource] /Metabolic diseases and gut bacteriaedited by Indu Pal Kaur ... [et al.]. - Singapore :Springer Nature Singapore :2022. - xiv, 275 p. :ill., digital ;24 cm.

Chapter 1: Gut-Brain Axis: Role in Hunger and Satiety -- Chapter 2: Antiobesity Activities of Probiotics and Dairy based Ingredients -- Chapter 3: Effect of Pre/Probiotic Supplementation on Metabolic Endotoxemia -- Chapter 4: Probiotics in the management of Diabetes -- Chapter 5: Intestinal microbiota modulation for type 1 and type 2 diabetes prevention -- Chapter 6: Mechanisms of beneficial effects of probiotics in diabetes mellitus -- Chapter 7: Preventive and therapeutic role of Probiotics in type- 2 diabetes and its associated complications -- Chapter 8: Protective effect of probiotic in alcohol induced liver disorders -- Chapter 9: Molecular Mechanism of Beneficial Effects of Probiotics in Alcohol-Induced Liver Disorder -- Chapter 10: Effect of probiotic supplementation on modulation of serum lipids -- Chapter 11: Use of prebiotics for addressing gut dysbiosis and achieving healthy gut- brain axis -- Chapter 12: Designer Probiotics in Metabolic Disorders -- Chapter 13: Animal models used for studying the benefits of probiotics in metabolic disorders.

This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included. The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.

ISBN: 9789811684449

Standard No.: 10.1007/978-981-16-8444-9doiSubjects--Topical Terms:

783841
Probiotics.

LC Class. No.: QR171.G29 / P76 2022

Dewey Class. No.: 612.3601579

Probiotic research in therapeutics.. Volume 5,. Metabolic diseases and gut bacteria
LDR:03190nam a2200337 a 4500 001 1115591
003 DE-He213
005 20220504151110.0
006 m d
007 cr nn 008maaau
008 240123s2022 si s 0 eng d
020 $a 9789811684449 $q (electronic bk.)
020 $a 9789811684432 $q (paper)
024 7 $a 10.1007/978-981-16-8444-9 $2 doi
035 $a 978-981-16-8444-9
040 $a GP $c GP
041 0 $a eng
050 4 $a QR171.G29 $b P76 2022
072 7 $a PSB $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a PNB $2 thema
082 0 4 $a 612.3601579 $2 23
090 $a QR171.G29 $b P962 2022
245 0 0 $a Probiotic research in therapeutics. $n Volume 5, $p Metabolic diseases and gut bacteria $h [electronic resource] / $c edited by Indu Pal Kaur ... [et al.].
246 3 0 $a Metabolic diseases and gut bacteria
260 $a Singapore : $c 2022. $b Springer Nature Singapore : $b Imprint: Springer,
300 $a xiv, 275 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1: Gut-Brain Axis: Role in Hunger and Satiety -- Chapter 2: Antiobesity Activities of Probiotics and Dairy based Ingredients -- Chapter 3: Effect of Pre/Probiotic Supplementation on Metabolic Endotoxemia -- Chapter 4: Probiotics in the management of Diabetes -- Chapter 5: Intestinal microbiota modulation for type 1 and type 2 diabetes prevention -- Chapter 6: Mechanisms of beneficial effects of probiotics in diabetes mellitus -- Chapter 7: Preventive and therapeutic role of Probiotics in type- 2 diabetes and its associated complications -- Chapter 8: Protective effect of probiotic in alcohol induced liver disorders -- Chapter 9: Molecular Mechanism of Beneficial Effects of Probiotics in Alcohol-Induced Liver Disorder -- Chapter 10: Effect of probiotic supplementation on modulation of serum lipids -- Chapter 11: Use of prebiotics for addressing gut dysbiosis and achieving healthy gut- brain axis -- Chapter 12: Designer Probiotics in Metabolic Disorders -- Chapter 13: Animal models used for studying the benefits of probiotics in metabolic disorders.
520 $a This volume focuses on the potential use of probiotics in treating metabolic disorders such as diabetes mellitus, metabolic acidosis, and gut dysbiosis. Chapters draw an association between gut microbiota and its diversity with metabolic diseases like diabetes, obesity, related liver and gut disorders; gut-brain axis; increased inflammation, and a compromised immune system resulting from these manifestations and scope of intervention with probiotics. Special attention is laid on describing the mechanisms of action of such beneficial effects of probiotic administration. The ability of probiotics to decrease metabolic endotoxemia by restoring the disrupted intestinal mucosal barrier is also included. The volume is a comprehensive compilation describing the scope and application of probiotic and prebiotic therapy in treating metabolic disorders. Readers will discover how probiotics are not just confined to the microbiology industry but are showing promising results in the medical and pharmaceutical sectors.
650 0 $a Probiotics. $3 783841
650 0 $a Gastrointestinal system $x Microbiology. $3 783842
650 0 $a Nervous system $x Degeneration. $3 668516
650 0 $a Pharmaceutical technology. $3 557391
650 1 4 $a Pharmaceutics. $3 1366841
650 2 4 $a Health Sciences. $3 1365910
650 2 4 $a Pharmacology. $3 583819
650 2 4 $a Pharmacy. $3 582411
650 2 4 $a Analytical Chemistry. $3 668584
700 1 $a Kaur, Indu Pal. $3 1428568
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-8444-9
950 $a Chemistry and Materials Science (SpringerNature-11644)